Escalon Medical Corporation (ESMC)
| Market Cap | 1.93M |
| Revenue (ttm) | 9.68M |
| Net Income (ttm) | -746,092 |
| Shares Out | 7.42M |
| EPS (ttm) | -0.10 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 5 |
| Last Price | $0.2600 |
| Previous Close | $0.2400 |
| Change ($) | 0.0200 |
| Change (%) | 8.33% |
| Day's Open | 0.2401 |
| Day's Range | 0.2351 - 0.2600 |
| Day's Volume | 10,569 |
| 52-Week Range | 0.082 - 0.26 |
News
There are no news available yet.
About ESMC
Escalon Medical develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thicknes... [Read more...]
| Industry Medical Devices | IPO Date Sep 11, 1992 |
| CEO Richard J. DePiano Jr. | Employees 38 |
| Stock Exchange OTCMKTS | Ticker Symbol ESMC |
Financial Performance
In 2020, ESMC's revenue was $9.40 million, a decrease of -2.35% compared to the previous year's $9.63 million. Losses were -$650,280, 160.1% more than in 2019.